ArticleBMC cardiovascular disorders2025
Global burden and trend of rheumatic heart disease among women of childbearing age, 1990-2021, with projection to 2040.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Valve biology and rheumatic heart disease pathogenesis.Nature cardiovascular research · 2026Review
- Global, Regional, and Future Predictions of Cardiovascular Disease Burden Among Women of Childbearing Age: A Systematic Analysis of the Global Burden of Disease Study 1990-2021.International journal of women's health · 2026Article
- Integrating equity and justice in rheumatic heart disease policy: addressing reproductive health challenges.International journal of public health · 2026Article
- Can transesophageal echocardiography be safely deferred? A low-cost predictive model using D-dimer to exclude left atrial thrombus in treatment-naïve rheumatic mitral stenosis.Frontiers in cardiovascular medicine · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aims to assess the global burden, trends, and regional variations of rheumatic heart disease (RHD) among women of childbearing age (WCBA), contributing to better-targeted prevention and management strategies.
methodsData from the Global Burden of Disease Study (GBD) 2021 were analyzed to estimate the incidence, mortality, and disability-adjusted life years (DALYs) due to RHD among WCBA globally and by region from 1990 to 2021. Projections of the RHD incidence rate from 2022 to 2040 were generated using the Bayesian age-period-cohort model.
resultsIn 2021, there were 1,248,510 new cases of RHD among WCBA, with an age-standardized incidence rate (ASIR) of 64.31 per 100,000 population. RHD resulted in 40,195 deaths and 3,190,496 DALYs, with age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) of 2.06 and 163.51 per 100,000, respectively. The global burden of RHD showed a slight increase in incidence (0.36% per year) from 1990 to 2021, while mortality and DALYs decreased by 2.85% and 2.04%, respectively. Regionally, Sub-Saharan Africa had the highest ASIR, while high-income regions like Western Europe showed the lowest. RHD burden was more pronounced in low- Sociodemographic Index (SDI) regions, with a declining trend in high-SDI regions. Projections indicate continued increases in ASIR globally, particularly in regions with fluctuating trends like South Asia and Sub-Saharan Africa.
conclusionIn conclusion, RHD remains a significant health challenge for women of childbearing age, especially in low- and middle-SDI regions where the burden is highest. Despite declines in global mortality and DALYs, incidence continues to rise in several areas, particularly among younger females. We recommend implementing integrated RHD screening programs in primary care, with a focus on adolescent girls and women in low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.